Evolent Health (EVH) to Acquire Valence Health in $145M Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Leerink Partners Remains Bullish on Evolent Health (EVH) Following Investor Call
July 13, 2016 1:31 PM EDTLeerink Partners reiterated an Outperform rating and $20.00 price target on Evolent Health (NYSE: EVH) following the company's call with investors. On the call management highlighted that they would expect Valence to continue to grow in the ~30% range in 2017. Management also believes that their... More
FBR Capital Raises Price Target on Evolent Health (EVH) to $24 Following Valence Health Acquisitions
July 13, 2016 11:16 AM EDTFBR Capital reiterated an Outperform rating on Evolent Health (NYSE: EVH), and raised the price target to $24.00 (from $16.00), following the company's announced acquisition of most of the assets of Valence Health. In addition to bringing new expertise, EVH will benefit from using Valent for... More
